U.S. Electronic Equipment and Components Stock News

NYSE:LH
NYSE:LHHealthcare

Is It Too Late To Reconsider Labcorp Holdings (LH) After Recent Share Price Pullback

Wondering if Labcorp Holdings at around US$258 a share still offers value, or if most of the opportunity is already priced in? This article walks through the key signals you can use to judge that for yourself. The stock has been fairly steady over the last week with a 0.5% return, has a 4.1% decline over the past month, yet sits on a 4.8% return over 1 year and 41.6% over 3 years. This raises the question of whether the current price reflects the business fundamentals. Recent headlines...
NYSE:AVY
NYSE:AVYPackaging

A Look At Avery Dennison (AVY) Valuation After Recent Share Price Weakness

How Avery Dennison (AVY) Has Been Trading Recently Avery Dennison (AVY) has seen mixed share performance recently, with a 0.7% decline over the past day, a 1% gain over the past week, and a 1.2% decline over the past month. Over the past 3 months, the stock shows a 13.6% decline, with a year to date return of negative 9.3% and a 1 year total return of negative 2.3%. Longer term, the 3 year total return stands at 1.5%, while the 5 year total return is negative 18.3%. See our latest analysis...
NYSE:JXN
NYSE:JXNDiversified Financial

How Jackson’s Q1 Loss, Annuity Momentum and TPG Deal At Jackson Financial (JXN) Has Changed Its Investment Story

In early May 2026, Jackson Financial Inc. reported first-quarter 2026 results showing revenue of US$2,902 million and a net loss of US$424 million, while also continuing to return capital through dividends and share repurchases under its multi-year buyback program. Beneath the headline loss, the company highlighted strong retail annuity momentum, a very large share repurchase completion since 2021, and a new TPG partnership aimed at supporting product diversification and capital...
NYSE:UI
NYSE:UICommunications

Ubiquiti (UI) Earnings Surge And 29.9% Margin Spark Debate On Valuation Premium

Ubiquiti (UI) has put up another big quarter, with Q2 2026 revenue of US$814.9 million and basic EPS of US$3.86, while trailing 12 month EPS sits at US$14.69 on revenue of about US$3.0 billion and earnings growth over that period is described as a 99.7% jump. The company has seen quarterly revenue move from US$599.9 million and EPS of US$2.26 in Q2 2025 to US$814.9 million and EPS of US$3.86 in Q2 2026, and trailing 12 month net profit margin is now stated at 29.9% versus 20.7% a year...
NasdaqGS:LSCC
NasdaqGS:LSCCSemiconductor

How Lattice's Earnings Beat and AMI Deal Could Reshape Lattice Semiconductor (LSCC) Investors' Risk-Reward Profile

Lattice Semiconductor reported past Q1 2026 results with revenue of US$170.9 million and net income of US$21.82 million, beating market expectations and issuing Q2 revenue guidance of US$175 million to US$195 million. The company also announced an agreement to acquire AMI for about US$1.65 billion, aiming to combine low-power FPGAs with firmware and manageability software to broaden its role in AI servers and cloud infrastructure. Next, we’ll examine how this earnings beat and AMI...
NYSE:NMM
NYSE:NMMShipping

Does Navios Maritime Partners’ 20% Payout Hike Signal a New Capital Return Strategy for NMM?

Navios Maritime Partners L.P. recently announced that its Board of Directors approved a cash distribution of US$0.06 per unit for the quarter ended March 31, 2026, a 20% increase over the prior quarter, payable on May 14, 2026 to holders of record as of May 11, 2026. This higher quarterly payout, equivalent to an annualized US$0.24 per unit, highlights management’s willingness to return more cash to unitholders and may influence how investors assess its income profile. We will now examine...
NasdaqGS:GT
NasdaqGS:GTAuto Components

A Look At Goodyear Tire & Rubber (GT) Valuation After First Quarter 2026 Loss And Cost Pressures

Goodyear Tire & Rubber (GT) reported first quarter 2026 results, with sales of US$3,881 million and a net loss of US$249 million, as tyre volumes and input costs weighed on performance. See our latest analysis for Goodyear Tire & Rubber. At a share price of US$6.86, Goodyear’s 1 day share price return of 6.03% decline and 7 day share price return of 3.11% decline came after the first quarter loss and ongoing cost pressures. The 1 year total shareholder return of 37.29% decline underlines that...
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Has Clover Health Investments (CLOV) Share Surge Left More Room Based On Cash Flow Value?

Wondering whether Clover Health Investments at US$2.82 is still a bargain or already pricing in its prospects? This breakdown will help you judge what you are really paying for. The stock has had a strong run over shorter periods, with returns of 2.5% over 7 days, 48.4% over 30 days and 17.0% year to date. However, the 1 year return sits at a 24.8% decline and the 3 year return is very large at 196.7% compared to a 61.2% decline over 5 years. Recent headlines have focused on the company as a...
NasdaqCM:NESR
NasdaqCM:NESREnergy Services

A Look At National Energy Services Reunited (NESR) Valuation After Recent Share Price Moves

National Energy Services Reunited stock reaction National Energy Services Reunited (NESR) has drawn attention after recent trading that left the stock at US$23.35, with short term moves contrasting with gains over the month and the past 3 months. See our latest analysis for National Energy Services Reunited. Although the 1 day share price return of 5.81% and 7 day share price return of 6.38% are weak, the 1 month and year to date share price returns of 7.70% and 47.88% alongside a very large...
NYSE:MTN
NYSE:MTNHospitality

Vail Resorts (MTN) Valuation Check After Oil-Driven Sector Rally

Oil-driven sector move puts Vail Resorts (MTN) in focus Vail Resorts (MTN) climbed 3% after crude oil prices fell sharply on hopes for a deal to reopen the Strait of Hormuz, a move that could ease fuel related costs across travel and leisure stocks. See our latest analysis for Vail Resorts. Today’s move sits against a weaker backdrop, with a 30 day share price return of 3.43% and a year to date share price return of a 6.49% decline, while the 5 year total shareholder return of a 50.96%...
NasdaqGS:ANDE
NasdaqGS:ANDEConsumer Retailing

Andersons (ANDE) Is Down 9.8% After Record Q1 Boosted By Clean Fuel Credits - What's Changed

The Andersons, Inc. reported first-quarter 2026 sales of US$2,627.27 million, with net income rising to US$33.19 million and diluted EPS from continuing operations increasing to US$0.97, marking its strongest first quarter on record. This profit surge was fueled by improved Agribusiness and Renewables performance and the recognition of US$26.2 million in Section 45Z clean fuel production credits, alongside ongoing investments in soybean meal export capacity and ethanol plant...
NasdaqGS:FLEX
NasdaqGS:FLEXElectronic

Assessing Flex (FLEX) Valuation After Earnings Beat And Planned Cloud And Power Infrastructure Spin Off

Flex (FLEX) is in focus after reporting Q4 and fiscal 2026 results that exceeded analyst expectations, and pairing the earnings beat with plans to spin off its Cloud and Power Infrastructure segment. See our latest analysis for Flex. The share price has been on a strong run, with a 30 day share price return of 95.05% and a year to date share price return of 108.93%. The one year total shareholder return of 245.39% points to powerful momentum that recent earnings, guidance and the spin off...
NasdaqGS:LYFT
NasdaqGS:LYFTTransportation

Lyft (LYFT) Posts 45% Net Margin And Profitability Spike That Challenges Bearish Narratives

Lyft (LYFT) closed FY 2025 with fourth quarter revenue of US$1,592.7 million and basic EPS of US$6.88, setting a high bar for a year in which trailing 12 month EPS reached US$6.92 and revenue stood at US$6.3 billion alongside very large year over year earnings growth and a 45% net profit margin. Over the past six quarters, the company has seen quarterly revenue move from US$1,522.7 million in Q3 2024 to between US$1,450.2 million and US$1,685.2 million across FY 2025, while basic EPS ranged...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

A Look At Exelixis (EXEL) Valuation After Strong Q1 2026 Results And Zanzalintinib FDA Milestone

Why Exelixis stock is on investors’ radar after Q1 2026 Exelixis (EXEL) is back in focus after first quarter 2026 earnings, with revenue of US$610.81 million, net income of US$210.47 million, and FDA progress on zanzalintinib alongside active share repurchases. See our latest analysis for Exelixis. The stock has cooled slightly after earnings, with a 1 day share price decline of 5.11% to US$46.21. However, a 1 year total shareholder return of 26.60% and a 3 year total shareholder return of...
NasdaqGS:VNET
NasdaqGS:VNETIT

Is VNET Group (NasdaqGS:VNET) Undervalued After Mixed Recent Share Price Performance

Recent performance snapshot for VNET Group (NasdaqGS:VNET) With no single headline event driving attention, VNET Group (NasdaqGS:VNET) is back on investors’ radar after mixed recent returns and improving annual revenue and net income figures, which contrast with its current loss-making position. See our latest analysis for VNET Group. VNET Group’s share price has been choppy, with a 7.82% 7 day share price return and 12.70% 30 day share price return contrasting with a 20% 90 day share price...
NasdaqGM:XENE
NasdaqGM:XENEBiotechs

The Bull Case For Xenon Pharmaceuticals (XENE) Could Change Following Positive X‑TOLE2 Data And FDA NDA Plans

In the first quarter ended March 31, 2026, Xenon Pharmaceuticals reported a net loss of US$102.3 million, or US$1.17 per share, while highlighting that it still has no marketed products and relies on collaboration revenues. More importantly for the company’s evolution, Xenon released positive Phase 3 X-TOLE2 data for its epilepsy candidate azetukalner and outlined plans to submit a New Drug Application to the FDA in the third quarter of 2026, underpinned by an expanded cash position of...
NasdaqGS:EXPE
NasdaqGS:EXPEHospitality

Expedia Group (EXPE) Net Margin Slip To 8.8% Tests Bullish AI Profitability Narrative

Expedia Group (EXPE) has wrapped up FY 2025 with fourth quarter revenue of US$3,547 million and basic EPS of US$1.67, alongside trailing twelve month revenue of US$14.7 billion and EPS of US$10.32. This provides a clear snapshot of scale and earnings power. Over recent quarters, the company has seen revenue range from US$2,988 million to US$4,412 million and quarterly EPS move between a loss of US$1.55 and a high of US$7.75. This gives investors a wide band of outcomes to weigh against the...
NasdaqGS:ISRG
NasdaqGS:ISRGMedical Equipment

Assessing Intuitive Surgical (ISRG) Valuation After Recent Share Pullback And Recurring Revenue Focus

Context for Intuitive Surgical’s recent share performance Intuitive Surgical (ISRG) has drawn renewed attention after a period where the stock is roughly flat over the past month and shows a negative move over the past 3 months, prompting investors to reassess its fundamentals. With a market value near US$160b and annual revenue of US$10.58b, the company sits at scale in robotic and minimally invasive medical equipment, giving investors plenty of hard numbers to weigh against recent share...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

CoreWeave (CRWV) Q4 Loss Of US$452m Reinforces Profitability Concerns Despite Revenue Scale

CoreWeave (CRWV) has just wrapped up FY 2025 with Q4 total revenue of US$1.6b, a basic EPS loss of US$0.89 and net income loss of US$452.0m. This caps off a year in which trailing twelve month revenue reached US$5.1b alongside a TTM basic EPS loss of US$2.75. Over the past six reported quarters, the company has seen revenue move from US$584.0m in Q3 2024 to US$1.6b in Q4 2025. During the same period, quarterly basic EPS has ranged between a loss of US$0.22 and a loss of US$1.82, so the latest...
NYSE:MC
NYSE:MCCapital Markets

A Look At Moelis (MC) Valuation After Q1 Earnings, Buybacks, Dividend And New Shelf Registrations

What Moelis’ latest filings mean for stock watchers Moelis (MC) just combined a softer first quarter, fresh buyback data, a maintained cash dividend, and new shelf registrations for Class A shares, giving you several moving pieces to weigh at once. See our latest analysis for Moelis. After these filings and the softer first quarter, Moelis is trading at US$63.91, with a 30 day share price return of 11.15% but a 10.26% decline year to date. The 1 year total shareholder return of 19.41% and 3...
NYSE:JOBY
NYSE:JOBYAirlines

Why Joby Aviation (JOBY) Is Up 8.9% After NYC eVTOL Demo Flights and FAA Progress

In the first quarter of 2026, Joby Aviation reported sales of US$24.25 million and a net loss of US$109.95 million, while basic loss per share from continuing operations was US$0.12, slightly higher than a year earlier. During April 2026, Joby also completed New York City’s first-ever point-to-point electric air taxi demonstration flights, linking JFK Airport with multiple Manhattan heliports and highlighting progress toward FAA certification and urban air mobility services. We’ll now look...
NYSE:MUR
NYSE:MUROil and Gas

Is Murphy Oil (MUR) Still Attractive After An 88% One Year Share Price Surge

If you are wondering whether Murphy Oil at around US$38.27 is offering value or just riding momentum, the recent share performance gives you plenty to think about. The stock has seen a 1 year return of 88.2% and is up 17.8% year to date, despite shorter term pullbacks with a 7 day return showing an 8.4% decline and a 30 day return showing a 10.5% decline. Recent coverage has focused on Murphy Oil as part of broader conversations around US oil and gas stocks, with attention on how producers...
NasdaqCM:LQDA
NasdaqCM:LQDAPharmaceuticals

Liquidia (LQDA) Is Up 7.8% After EPS, Revenue Beat Forecasts And Insider 10b5-1 Sales - What's Changed

In recent days, Liquidia Corporation announced its upcoming first-quarter 2026 earnings release, alongside expectations from analysts for higher earnings per share and stronger revenue than the prior year, while also disclosing CEO-related insider share sales executed under pre-set Rule 10b5-1 trading plans. The combination of anticipated earnings growth tied to Liquidia’s pulmonary hypertension franchise and insider transactions has sharpened investor focus on how its PRINT-enabled...
NasdaqGS:PTEN
NasdaqGS:PTENEnergy Services

Assessing Patterson‑UTI Energy (PTEN) Valuation After A Strong Year Of Share Price Gains

How Patterson-UTI Energy Stock Has Been Performing Patterson-UTI Energy (PTEN) has drawn attention after a strong year, with the stock up about 76% year to date and delivering a total return of roughly 106% over the past 12 months. Over shorter periods, performance has been mixed, with a 1% decline in the last session, a 7% decline over the past week, and small gains over the past month, while the past 3 months show a return of about 32%. See our latest analysis for Patterson-UTI Energy. The...